Aquestive Therapeutics

Update in progress

AQST (NasdaqGM)

Company RatingNeutral
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic

Aquestive Therapeutics, Inc. is a Warren, New Jersey-based pharmaceutical company focused on advanced drug delivery. It offers Libervant (buccal diazepam) for seizures; Suboxone (buprenorphine/naloxone) sublingual film for opioid dependence; EMYLIF, ONDIF, and SYMPAZAN films for epilepsy and seizures; KYNMOBI (apomorphine) and AZSTARYS (ADHD, 6+). Its pipeline includes Anaphylm (epinephrine sublingual film) in Phase 3 and AQST-108 topical gel in Phase 2, plus PharmFilm and Adrenaverse technologies.

Company score

Sentiment: 0.04; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.03; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: -0.04; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.00; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.02; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive